Insight Molecular Diagnostics (IMDX) vs Trinity Biotech (TRIB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Insight Molecular Diagnostics is the larger company by market cap ($107.3 million vs $4.9 million), about 21.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMDX | TRIB |
|---|---|---|
| Share price | $3.28 | $6.04 |
| Market cap | $107.34M | $4.91M |
| 1-day change | -5.20% | -10.91% |
| YTD return | -56.27% | — |
| 1-year return | -10.87% | — |
| 5-year return | -95.18% | — |
| EPS (TTM) | $-1.52 | $-60.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.51 | $52.50 |
| 52-week low | $2.42 | $5.01 |
| Distance from 52-week high | -61.46% | -88.50% |
| Analyst consensus | none | — |
| Avg. price target upside | +151.52% | — |
| Average volume | 232.87K | 21.66K |
| Shares outstanding | 32.72M | 813.13K |
| Employees | 55 | 287 |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Insight Molecular Diagnostics is about 21.9 times larger than Trinity Biotech by market value ($107.34M vs $4.91M).
About Insight Molecular Diagnostics
IMDX stock →Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally.
Healthcare · Diagnostics & Research · 55 employees
About Trinity Biotech
TRIB stock →Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Healthcare · Medical Devices · 287 employees
IMDX vs TRIB FAQ
Which is bigger, Insight Molecular Diagnostics or Trinity Biotech?
Insight Molecular Diagnostics (IMDX) is larger, with a market capitalization of $107.34M compared with $4.91M for Trinity Biotech (TRIB).
Are Insight Molecular Diagnostics and Trinity Biotech in the same industry?
Both are in the Healthcare sector, but in different industries: Diagnostics & Research for Insight Molecular Diagnostics and Medical Devices for Trinity Biotech.